• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establishment and Analysis of Enzym Immunoassay for Novel Immunosuppressant, FTY720

Research Project

Project/Area Number 13672331
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 医薬分子機能学
Research InstitutionRESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT

Principal Investigator

FUJITA Tetsuro  RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT RESEARCHER, 創薬設計研究室, 研究員 (40027024)

Co-Investigator(Kenkyū-buntansha) KOHNO Takeyuki  SETSU NAN UNIVERSITY FACULTY OF PHARMACEUTICAL SCIENCES ASSOCIATE PROFESSOR, 薬学部, 助教授 (50178224)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 2002: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2001: ¥2,000,000 (Direct Cost: ¥2,000,000)
KeywordsIMMUNOSUPPRESSANT / FTY720 / ENZYME IMMUNOASSAY / HAPTEN / ORGAN TRANSPLANT / PHARMACOKINETICS / EIPITOPE ANALYSIS / PHARMACO-BINDING SITE / 薬部動態
Research Abstract

Immunosuppressants have important clinical roles in organ transplantation and the treatment of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and psoriasis. Both cyclosporin A (CsA) and tacrolimus (FK506) suppress immune responses by inhibiting the production of interleukin-2 (IL-2) in antigen-stimulated helper T-cells, and are standard medicines for preventing graft rejection after transplant surgery. Since their clinical use is restricted by severe side effects, notably renal and liver toxicities, they are used in combination with glucocorticoids or other immunosuppressants such as azathioprine and mizoribine. Novel immunosuppressants should therefore not only be safer but also possess unique mechanisms of action.
In the late 1980s Fujita et al. of our group isolated a unique immunosuppressant, ISP-I (myriocin), from the fermentation broth of Isaria sinclairii (ATCC24400). It has been reported that ISP-I inhibits serine palmitoyltransferase of an IL-2 … More dependent mouse cytotoxic T cell line, CTLL-2,at picomole concentrations. We simplified the structure of ISP-I in order to reduce its toxicity, to improve its physicochemical properties, and to identify the structure essential for immunosuppressive activity to give FTY720 (2-amino-2-(2-(4-(octylphenyl)ethyl)propane-1 ,3-diol
In spite of the established therapeutic effectiveness of FTY720, little clinical and experimental knowledge is yet available about its pharmacokinetic properties, disposition, and so on, due to the lack of an antibody against FTY720. An antibody was prepared by immunizing rabbits with an ovalbumin conjugate of 2-amino-2-(2-(4-(4-mercaptobutyl)phenyl)ethyl)propane-l ,3-diol HCl (AMPD-4), which contains the essential structure of the novel immunosuppressant FTY720. As the antibody reacted to not only AMPD-4, but also FTY720, it should be useful for immunoassay of FTY720 in body fluids, tissues and cells. However, the antibody showed a cross immuno-reaction with FTY720 metabolites. This report deals with synthesis of hapten, AMPD-8, which is closer to FTY720, and preparation of monoclonal antibody against FTY720. Less

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] 河野武幸: "実験的重症筋無力症モデルマウスのTh1/Th2サイトカインmRNA産生量と新規免疫抑制剤(FTY720)の影響"Neuroimmunology. 11(1). 103 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takeyuki Kohno, et al: "Production of Th1/Th2-cytokine mRNA in the experimental myasthenia gravis model mouse and the effect of a novel immunosuppressant, FTY720."Neuroimmunology. 11(1). 103 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 河野武幸, 辻 琢己, 平山かおり, 渡部一仁, 藤多哲朗, 林 正俊: "実験的重症筋無力症モデルマウスのTh1/Th2サイトカインmRNA産生量と新規免疫抑制剤(FTY720)の影響"日本神経免疫学会機関誌. 11・1. 103 (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi